A Cost-Effectiveness Analysis of a Pilot Neonatal Screening Program for Sickle Cell Anemia in the Republic of Angola

Journal of Pediatrics

Volumn 167, Issue 6, 2015, Pages 1314-1319

  McGann, Patrick T ^a   Grosse, Scott D ^b   Santos, Brigida ^c   de Oliveira, Vysolela ^c   Bernardino, Luis ^c   Kassebaum, Nicholas J ^d   Ware, Russell E ^a   Airewele, Gladstone E ^e  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^c Hospital Pediatrico David Bernardino   (Angola)

^d SEATTLE CHILDREN S HOSPITAL   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGOLA; ARTICLE; COST EFFECTIVENESS ANALYSIS; GLOBAL DISEASE BURDEN; GROSS NATIONAL PRODUCT; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN MORBIDITY; NEWBORN MORTALITY; NEWBORN PERIOD; NEWBORN SCREENING; PATIENT CARE; PILOT STUDY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; SICKLE CELL ANEMIA; ANEMIA, SICKLE CELL; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; FOLLOW UP; INFANT; INFANT MORTALITY; MALE; MORBIDITY; TRENDS;

ANEMIA, SICKLE CELL; ANGOLA; COST-BENEFIT ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; MALE; MORBIDITY; NEONATAL SCREENING; PILOT PROJECTS;

EID: 84951728572     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2015.08.068     Document Type: Article

References (33)

1. 1 Piel, F.B., Patil, A.P., Howes, R.E., Nyangiri, O.A., Gething, P.W., Dewi, M., et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet 381 (2013), 142–151.
2. 2 Fleming, A.F., Storey, J., Molineaux, L., Iroko, E.A., Attai, E.D., Abnormal haemoglobins in the Sudan savanna of Nigeria. I. Prevalence of haemoglobins and relationships between sickle cell trait, malaria and survival. Ann Trop Med Parasitol 73 (1979), 161–172.
3. 3 Grosse, S.D., Odame, I., Atrash, H.K., Amendah, D.D., Piel, F.B., Williams, T.N., Sickle cell disease in Africa: a neglected cause of early childhood mortality. Am J Prev Med 41 (2011), S398–S405.
4. 4 Piel, F.B., Hay, S.I., Gupta, S., Weatherall, D.J., Williams, T.N., Global Burden of Sickle Cell Anaemia in Children under Five, 2010-2050: modelling based on demographics, excess mortality, and interventions. PLoS Med, 10, 2014, e1001484.
5. 5 Telfer, P., Coen, P., Chakravorty, S., Wilkey, O., Evans, J., Newell, H., et al. Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica 92 (2007), 905–912.
6. 6 Quinn, C.T., Rogers, Z.R., McCavit, T.L., Buchanan, G.R., Improved survival of children and adolescents with sickle cell disease. Blood 115 (2010), 3447–3452.
7. 7 Grosse, S.D., Atrash, H.K., Odame, I., Amendah, D., Piel, F.B., Williams, T.N., The Jamaican historical experience of the impact of educational interventions on sickle cell disease child mortality. Am J Prev Med 42 (2012), e101–e103.
8. 8 King, L., Fraser, R., Forbes, M., Grindley, M., Ali, S., Reid, M., Newborn sickle cell disease screening: the Jamaican experience (1995-2006). J Med Screen 14 (2007), 117–122.
9. 9 Panepinto, J.A., Magid, D., Rewers, M.J., Lane, P.A., Universal versus targeted screening of infants for sickle cell disease: a cost-effectiveness analysis. J Pediatr 136 (2000), 201–208.
10. 10 Grosse, S.D., Olney, R.S., Baily, M.A., The cost effectiveness of universal versus selective newborn screening for sickle cell disease in the US and the UK: a critique. Appl Health Econ Health Policy 4 (2005), 239–247.
11. 11 McGann, P.T., Ferris, M.G., Ramamurthy, U., Santos, B., de Oliveira, V., Bernardino, L., et al. A prospective newborn screening and treatment program for sickle cell anemia in Luanda, Angola. Am J Hematol 88 (2013), 984–989.
12. 12 Odunvbun, M.E., Okolo, A.A., Rahimy, C.M., Newborn screening for sickle cell disease in a Nigerian hospital. Public Health 122 (2008), 1111–1116.
13. 13 Rahimy, M.C., Gangbo, A., Ahouignan, G., Alihonou, E., Newborn screening for sickle cell disease in the Republic of Benin. J Clin Pathol 62 (2009), 46–48.
14. 14 Tshilolo, L., Aissi, L.M., Lukusa, D., Kinsiama, C., Wembonyama, S., Gulbis, B., et al. Neonatal screening for sickle cell anaemia in the Democratic Republic of the Congo: experience from a pioneer project on 31 204 newborns. J Clin Pathol 62 (2009), 35–38.
15. 15 Tshilolo, L., Kafando, E., Sawadogo, M., Cotton, F., Vertongen, F., Ferster, A., et al. Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies. Public Health 122 (2008), 933–941.
16. 16 Ohene-Frempong, K., Oduro, J., Tetteh, H., Nkrumah, F., Screening newborns for sickle cell disease in Ghana. Pediatrics 121 (2008), S120–S121.
17. 17 World Health Organization. Sickle-cell anaemia: report by the Secretariat. 59th World Health Assembly, April 24, 2006. Geneva; 2006.
18. 18 World Health Organization Regional Office for Africa. Sickle-cell disease: a strategy for the WHO African Region: report of the Regional Director. AFR/RC60/8; June 2010.
19. 19 Ware, R.E., Is sickle cell anemia a neglected tropical disease?. PLoS Negl Trop Dis, 7, 2013, e2120.
20. 20 World Health Organization. WHO Guide to Cost-Effectiveness Analysis. Geneva, http://www.who.int/choice/publications/p_2003_generalised_cea.pdf; 2003. Accessed February 14, 2015.
21. 21 World Bank. Official Exchange Rate. http://data.worldbank.org/indicator/PA.NUS.FCRF. Accessed February 14, 2015.
22. 22 World Bank. PPP Conversion factor (GDP) to market exchange rate ratio. http://data.worldbank.org/indicator/PA.NUS.PPPC.RF. Accessed February 14, 2015.
23. 23 Salomon, J.A., Vos, T., Hogan, D.R., Gagnon, M., Naghavi, M., Mokdad, A., et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 380 (2012), 2129–2143.
24. 24 Murray, C.J., Vos, T., Lozano, R., Naghavi, M., Flaxman, A.D., Michaud, C., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380 (2012), 2197–2223.
25. 25 Murray, C.J., Ezzati, M., Flaxman, A.D., Lim, S., Lozano, R., Michaud, C., et al. GBD 2010: design, definitions, and metrics. Lancet 380 (2012), 2063–2066.
26. 26 World Health Organization. WHO Global Health Observatory Data Repository. Geneva, http://apps.who.int/gho/data/node.main; 2012. Accessed February 14, 2015.
27. 27 Commission on Macroeconomics and Health. Macroeconomics and health: investing in health for economic development. 2001, World Health Organization, Geneva.
28. 28 Mortality among children with sickle cell disease identified by newborn screening during 1990-1994—California, Illinois, and New York. MMWR Morb Mortal Wkly Rep 47 (1998), 169–172.
29. 29 Wang, Y., Liu, G., Caggana, M., Kennedy, J., Zimmerman, R., Oyeku, S.O., et al. Mortality of New York children with sickle cell disease identified through newborn screening. Genet Med 17 (2015), 452–459.
30. 30 Amendah, D.D., Mukamah, G., Komba, A., Ndila, C., Williams, T.N., Routine Paediatric Sickle Cell Disease (SCD) Outpatient Care in a Rural Kenyan Hospital: utilization and costs. PLoS One, 8, 2013, e61130.
31. 31 Liu, L., Johnson, H.L., Cousens, S., Perin, J., Scott, S., Lawn, J.E., et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379 (2012), 2151–2161.
32. 32 Hill, K., You, D., Inoue, M., Oestergaard, M.Z., Technical Advisory Group of United Nations Inter-agency Group for Child Mortality Estimation. Child mortality estimation: accelerated progress in reducing global child mortality, 1990-2010. PLoS Med, 9, 2012, e1001303.
33. 33 Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380 (2012), 2095–2128.